为满足新药物研发的需求,ACROBiosystems采用荧光素酶报告基因系统(Luciferase Reporter Assay System)建立报告基因细胞平台,持续开发系列高质量报告基因细胞株产品。ACRO开发的系列细胞株产品均通过功能性和稳定性验证,可以应用于信号传导功能研究,早期药物发现,高通量药物筛选、生物活性测定、稳定性测定、批次放行等方面,为新药研发提供一个稳定且便捷的工具。
基于明确MOA设计,便于药物机制研究
反应信号强,确保高灵敏度
检测窗口大, 适用不同药效筛选
代次稳定性好,利于方法学验证
应用场景明确,方便客户选择
配套产品供应,实现一站服务<
细胞内信号转导通路研究
配体受体之间的相互作用研究
早期药物筛选和新药研发
货号 | Host cell | 产品描述 | Applications | 订购/预购 |
---|---|---|---|---|
CHEK-ATF044 | HEK293 | VEGFR2 (Luc) HEK293 Reporter Cell | Screen for anti-human VEGF or anti-human VEGFR neutralizing antibody | |
CHEK-ATF045 | HEK293 | TSLPR (Luc) HEK293 Reporter Cell | Screen for anti-human TSLP or anti-human TSLPR neutralizing antibody | |
CJUR-STF046 | Jurkat | NFAT (Luc) Jurkat Reporter Cell | Screen for T cell activators | |
CHEK-ATF047 | HEK293 | STAT3 (Luc) HEK293 Reporter Cell | Screen for STAT3 activators or inhibitors | |
CHEK-ATF048 | HEK293 | NF-κB (Luc) HEK293 Reporter Cell | Screen for NF-kB inhibitors and activators. | |
CHEK-ATF049 | HEK293 | EGFR (Luc) HEK293 Reporter Cell | Screen for anti-human EGFR or anti-human EGF neutralizing antibody or small molecule inhibitor | |
CHEK-ATF050 | HEK293 | NFAT (Luc) HEK293 Reporter Cell | Screen NFAT activators or inhibitors |
>>>如果您希望ACRO开发更多类型的报告基因细胞系产品,请点击提议
细胞性质验证
经FACS及Signaling Bioassay验证,Cat. No. CHEK-ATF045表达TSLPR及IL7R,用连续稀释的TSLP蛋白 (Cat. No.TSP-H52Hb)进行刺激,EC50值为0.1392 μg/mL,最大诱导倍数约为 45.15。
Co-expression analysis of human TSLPR and IL7Rα on TSLPR (Luc) HEK293 Reporter Cell by FACS. Cell surface staining was performed on TSLPR (Luc) HEK293 Reporter Cell or negative control cell using PE-labeled anti-TSLPR antibody and FITC-labeled anti-IL7Rα antibody.
Response to human TSLP protein (RLU). The TSLPR (Luc) HEK293 Reporter Cell was stimulated with serial dilutions of human TSLP protein (ACROBiosystems, Cat.No.TSP-H52Hb). The EC50 was approximately 0.1392 μg/mL.
Response to human TSLP protein (Fold). The TSLPR (Luc) HEK293 Reporter Cell was stimulated with serial dilutions of human TSLP protein (ACROBiosystems, Cat.No.TSP-H52Hb). The max induction fold was approximately 45.15.
代次稳定性验证
Passage stability analysis of receptors expression by FACS. Flow cytometry surface staining of human TSLPR and IL7Rα on TSLPR (Luc) HEK293 Reporter Cell demonstrates consistent mean fluorescent intensity across across passage10-26. (A) Human IL7Rα expression analysis. (B) Human TSLPR expression analysis.
Passage stability analysis by Signaling Bioassay. The continuously growing TSLPR (Luc) HEK293 Reporter Cell was stimulated with serial dilutions of human TSLP protein. Human TSLP protein stimulated response demonstrates passage stabilization (fold induction and EC50) across passage 10-26.
应用案例
经验证,抗TSLP抗体可以抑制TSLP蛋白(Cat. No. TSP-H52Hb)诱导的报告基因活性,EC50值为0.55 μg/mL。
2. EGFR (Luc) HEK293 Reporter Cell (Cat. No. CHEK-ATF049)
细胞性质验证
经FACS及Signaling Bioassay验证,Cat. No. CHEK-ATF049表达EGFR,用连续稀释的EGF蛋白 (Cat. No. EGF-H52H3)进行刺激,EC50值为56.23 ng/mL,最大诱导倍数约为56。
Expression analysis of human EGFR on EGFR (Luc) HEK293 Reporter Cell by FACS. Cell surface staining was performed on EGFR (Luc) HEK293 Reporter Cell or negative control cell using PE-labeled anti-EGFR antibody.
Response to human EGF protein (RLU). The EGFR (Luc) HEK293 Reporter Cell was stimulated with serial dilutions of human EGF protein (ACROBiosystems, Cat.No.EGF-H52H3). The EC50 was approximately 56.23 ng/mL.
Response to human EGF protein (Fold). The EGFR (Luc) HEK293 Reporter Cell was stimulated with serial dilutions of human EGF protein (ACROBiosystems, Cat.No.EGF-H52H3). The max induction fold was approximately 56.
代次稳定性验证
通过FACS及Signaling Bioassay对Cat. No. CHEK-ATF049传代稳定性进行验证,均证明该细胞株可稳定传递10-20代。
Passage stability analysis of receptor expression by FACS. Flow cytometry surface staining of human EGFR on EGFR (Luc) HEK293 Reporter Cell demonstrates consistent mean fluorescent intensity across across passage10-20.
Passage stability analysis by Signaling Bioassay. The continuously growing EGFR (Luc) HEK293 Reporter Cell was stimulated with serial dilutions of human EGF protein. Human EGF protein stimulated response demonstrates passage stabilization (fold induction and EC50) across passage 10-20.
应用案例
筛选中和抗体:经验证,抗EGFR抗体可以抑制EGF蛋白 (Cat. No. EGF-H52H3)诱导的报告基因活性,EC50值为1.793 μg/mL。
Inhibition of human EGF protein-induced reporter activity by anti-human EGFR neutralizing antibody. This reporter cell was incubated with serial dilutions of antibodies in the presence of human EGF protein (ACROBiosystems, Cat. No. EGF-H52H3) with a final concentration of 50 ng/mL. The EC50 of anti-human EGFR neutralizing antibody (Cetuximab) is approximately 1.793 μg/mL.
筛选小分子抑制剂:经验证,EGFR小分子抑制剂可以抑制EGF蛋白 (Cat. No. EGF-H52H3)诱导的报告基因活性,EC50值为0.01 μM。
Inhibition of human EGF protein-induced reporter activity by human EGFR small molecule inhibitor. This reporter cell was incubated with serial dilutions of inhibitors in the presence of human EGF protein (ACROBiosystems, Cat.No.EGF-H52H3) with a final concentration of 50 ng/mL. The EC50 of human EGFR small molecule inhibitor (Erlotinib) was approximately 0.01 μM.